Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200?days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study.

Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200?days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study. Transpl Infect Dis. 2017 Dec; 19(6).

View in: PubMed

subject areas

Adult
Antibiotic Prophylaxis
Antiviral Agents
Combined Modality Therapy
Cytomegalovirus
Cytomegalovirus Infections
Drug Administration Schedule
Female
Ganciclovir
Graft Rejection
Humans
Immunization, Passive
Immunoglobulins
Immunoglobulins, Intravenous
Kidney Transplantation
Liver Transplantation
Male
Middle Aged
Pilot Projects
Prospective Studies
Time Factors
Transplant Recipients

authors with profiles

Satish N. Nadig
David J. Taber
Prabhakar K Baliga
James N. Fleming